BTIG Remains a Hold on Staar Surgical (STAA)
BTIG analyst Ryan Zimmerman has maintained a Hold rating on Staar Surgical (STAA), with shares closing at $27.40. The analyst has an average return of -1.6% and a 40.57% success rate. The consensus rating for Staar Surgical is also a Hold, with an average price target of $28.00, indicating a potential upside of 2.19%. Canaccord Genuity similarly maintained a Hold rating with the same price target.
BTIG analyst Ryan Zimmerman maintained a Hold rating on Staar Surgical yesterday. The company’s shares closed yesterday at $27.40.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
According to TipRanks, Zimmerman is an analyst with an average return of -1.6% and a 40.57% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Stryker, Glaukos, and Intuitive Surgical.
The word on The Street in general, suggests a Hold analyst consensus rating for Staar Surgical with a $28.00 average price target, implying a 2.19% upside from current levels. In a report released on November 6, Canaccord Genuity also maintained a Hold rating on the stock with a $28.00 price target.
